Cargando…

Hypertension Is Associated with Marked Alterations in Sphingolipid Biology: A Potential Role for Ceramide

BACKGROUND: Hypertension is, amongst others, characterized by endothelial dysfunction and vascular remodeling. As sphingolipids have been implicated in both the regulation of vascular contractility and growth, we investigated whether sphingolipid biology is altered in hypertension and whether this i...

Descripción completa

Detalles Bibliográficos
Autores principales: Spijkers, Léon J. A., van den Akker, Rob F. P., Janssen, Ben J. A., Debets, Jacques J., De Mey, Jo G. R., Stroes, Erik S. G., van den Born, Bert-Jan H., Wijesinghe, Dayanjan S., Chalfant, Charles E., MacAleese, Luke, Eijkel, Gert B., Heeren, Ron M. A., Alewijnse, Astrid E., Peters, Stephan L. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3139577/
https://www.ncbi.nlm.nih.gov/pubmed/21818267
http://dx.doi.org/10.1371/journal.pone.0021817
_version_ 1782208471426400256
author Spijkers, Léon J. A.
van den Akker, Rob F. P.
Janssen, Ben J. A.
Debets, Jacques J.
De Mey, Jo G. R.
Stroes, Erik S. G.
van den Born, Bert-Jan H.
Wijesinghe, Dayanjan S.
Chalfant, Charles E.
MacAleese, Luke
Eijkel, Gert B.
Heeren, Ron M. A.
Alewijnse, Astrid E.
Peters, Stephan L. M.
author_facet Spijkers, Léon J. A.
van den Akker, Rob F. P.
Janssen, Ben J. A.
Debets, Jacques J.
De Mey, Jo G. R.
Stroes, Erik S. G.
van den Born, Bert-Jan H.
Wijesinghe, Dayanjan S.
Chalfant, Charles E.
MacAleese, Luke
Eijkel, Gert B.
Heeren, Ron M. A.
Alewijnse, Astrid E.
Peters, Stephan L. M.
author_sort Spijkers, Léon J. A.
collection PubMed
description BACKGROUND: Hypertension is, amongst others, characterized by endothelial dysfunction and vascular remodeling. As sphingolipids have been implicated in both the regulation of vascular contractility and growth, we investigated whether sphingolipid biology is altered in hypertension and whether this is reflected in altered vascular function. METHODS AND FINDINGS: In isolated carotid arteries from spontaneously hypertensive rats (SHR) and normotensive Wistar-Kyoto (WKY) rats, shifting the ceramide/S1P ratio towards ceramide dominance by administration of a sphingosine kinase inhibitor (dimethylsphingosine) or exogenous application of sphingomyelinase, induced marked endothelium-dependent contractions in SHR vessels (DMS: 1.4±0.4 and SMase: 2.1±0.1 mN/mm; n = 10), that were virtually absent in WKY vessels (DMS: 0.0±0.0 and SMase: 0.6±0.1 mN/mm; n = 9, p<0.05). Imaging mass spectrometry and immunohistochemistry indicated that these contractions were most likely mediated by ceramide and dependent on iPLA(2), cyclooxygenase-1 and thromboxane synthase. Expression levels of these enzymes were higher in SHR vessels. In concurrence, infusion of dimethylsphingosine caused a marked rise in blood pressure in anesthetized SHR (42±4%; n = 7), but not in WKY (−12±10%; n = 6). Lipidomics analysis by mass spectrometry, revealed elevated levels of ceramide in arterial tissue of SHR compared to WKY (691±42 vs. 419±27 pmol, n = 3–5 respectively, p<0.05). These pronounced alterations in SHR sphingolipid biology are also reflected in increased plasma ceramide levels (513±19 pmol WKY vs. 645±25 pmol SHR, n = 6–12, p<0.05). Interestingly, we observed similar increases in ceramide levels (correlating with hypertension grade) in plasma from humans with essential hypertension (185±8 pmol vs. 252±23 pmol; n = 18 normotensive vs. n = 19 hypertensive patients, p<0.05). CONCLUSIONS: Hypertension is associated with marked alterations in vascular sphingolipid biology such as elevated ceramide levels and signaling, that contribute to increased vascular tone.
format Online
Article
Text
id pubmed-3139577
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-31395772011-08-04 Hypertension Is Associated with Marked Alterations in Sphingolipid Biology: A Potential Role for Ceramide Spijkers, Léon J. A. van den Akker, Rob F. P. Janssen, Ben J. A. Debets, Jacques J. De Mey, Jo G. R. Stroes, Erik S. G. van den Born, Bert-Jan H. Wijesinghe, Dayanjan S. Chalfant, Charles E. MacAleese, Luke Eijkel, Gert B. Heeren, Ron M. A. Alewijnse, Astrid E. Peters, Stephan L. M. PLoS One Research Article BACKGROUND: Hypertension is, amongst others, characterized by endothelial dysfunction and vascular remodeling. As sphingolipids have been implicated in both the regulation of vascular contractility and growth, we investigated whether sphingolipid biology is altered in hypertension and whether this is reflected in altered vascular function. METHODS AND FINDINGS: In isolated carotid arteries from spontaneously hypertensive rats (SHR) and normotensive Wistar-Kyoto (WKY) rats, shifting the ceramide/S1P ratio towards ceramide dominance by administration of a sphingosine kinase inhibitor (dimethylsphingosine) or exogenous application of sphingomyelinase, induced marked endothelium-dependent contractions in SHR vessels (DMS: 1.4±0.4 and SMase: 2.1±0.1 mN/mm; n = 10), that were virtually absent in WKY vessels (DMS: 0.0±0.0 and SMase: 0.6±0.1 mN/mm; n = 9, p<0.05). Imaging mass spectrometry and immunohistochemistry indicated that these contractions were most likely mediated by ceramide and dependent on iPLA(2), cyclooxygenase-1 and thromboxane synthase. Expression levels of these enzymes were higher in SHR vessels. In concurrence, infusion of dimethylsphingosine caused a marked rise in blood pressure in anesthetized SHR (42±4%; n = 7), but not in WKY (−12±10%; n = 6). Lipidomics analysis by mass spectrometry, revealed elevated levels of ceramide in arterial tissue of SHR compared to WKY (691±42 vs. 419±27 pmol, n = 3–5 respectively, p<0.05). These pronounced alterations in SHR sphingolipid biology are also reflected in increased plasma ceramide levels (513±19 pmol WKY vs. 645±25 pmol SHR, n = 6–12, p<0.05). Interestingly, we observed similar increases in ceramide levels (correlating with hypertension grade) in plasma from humans with essential hypertension (185±8 pmol vs. 252±23 pmol; n = 18 normotensive vs. n = 19 hypertensive patients, p<0.05). CONCLUSIONS: Hypertension is associated with marked alterations in vascular sphingolipid biology such as elevated ceramide levels and signaling, that contribute to increased vascular tone. Public Library of Science 2011-07-19 /pmc/articles/PMC3139577/ /pubmed/21818267 http://dx.doi.org/10.1371/journal.pone.0021817 Text en Spijkers et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Spijkers, Léon J. A.
van den Akker, Rob F. P.
Janssen, Ben J. A.
Debets, Jacques J.
De Mey, Jo G. R.
Stroes, Erik S. G.
van den Born, Bert-Jan H.
Wijesinghe, Dayanjan S.
Chalfant, Charles E.
MacAleese, Luke
Eijkel, Gert B.
Heeren, Ron M. A.
Alewijnse, Astrid E.
Peters, Stephan L. M.
Hypertension Is Associated with Marked Alterations in Sphingolipid Biology: A Potential Role for Ceramide
title Hypertension Is Associated with Marked Alterations in Sphingolipid Biology: A Potential Role for Ceramide
title_full Hypertension Is Associated with Marked Alterations in Sphingolipid Biology: A Potential Role for Ceramide
title_fullStr Hypertension Is Associated with Marked Alterations in Sphingolipid Biology: A Potential Role for Ceramide
title_full_unstemmed Hypertension Is Associated with Marked Alterations in Sphingolipid Biology: A Potential Role for Ceramide
title_short Hypertension Is Associated with Marked Alterations in Sphingolipid Biology: A Potential Role for Ceramide
title_sort hypertension is associated with marked alterations in sphingolipid biology: a potential role for ceramide
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3139577/
https://www.ncbi.nlm.nih.gov/pubmed/21818267
http://dx.doi.org/10.1371/journal.pone.0021817
work_keys_str_mv AT spijkersleonja hypertensionisassociatedwithmarkedalterationsinsphingolipidbiologyapotentialroleforceramide
AT vandenakkerrobfp hypertensionisassociatedwithmarkedalterationsinsphingolipidbiologyapotentialroleforceramide
AT janssenbenja hypertensionisassociatedwithmarkedalterationsinsphingolipidbiologyapotentialroleforceramide
AT debetsjacquesj hypertensionisassociatedwithmarkedalterationsinsphingolipidbiologyapotentialroleforceramide
AT demeyjogr hypertensionisassociatedwithmarkedalterationsinsphingolipidbiologyapotentialroleforceramide
AT stroeseriksg hypertensionisassociatedwithmarkedalterationsinsphingolipidbiologyapotentialroleforceramide
AT vandenbornbertjanh hypertensionisassociatedwithmarkedalterationsinsphingolipidbiologyapotentialroleforceramide
AT wijesinghedayanjans hypertensionisassociatedwithmarkedalterationsinsphingolipidbiologyapotentialroleforceramide
AT chalfantcharlese hypertensionisassociatedwithmarkedalterationsinsphingolipidbiologyapotentialroleforceramide
AT macaleeseluke hypertensionisassociatedwithmarkedalterationsinsphingolipidbiologyapotentialroleforceramide
AT eijkelgertb hypertensionisassociatedwithmarkedalterationsinsphingolipidbiologyapotentialroleforceramide
AT heerenronma hypertensionisassociatedwithmarkedalterationsinsphingolipidbiologyapotentialroleforceramide
AT alewijnseastride hypertensionisassociatedwithmarkedalterationsinsphingolipidbiologyapotentialroleforceramide
AT petersstephanlm hypertensionisassociatedwithmarkedalterationsinsphingolipidbiologyapotentialroleforceramide